En-Qiang Chen (E-Q Chen, Enqiang Chen)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 38

Top Topics

Hepatitis C Virus

Mesenchymal Stem Cells

Total Hip Arthroplasty

Top Venues

Alimentary pharmacology & therapeutics

Journal of neurology

Journal of clinical and translational hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Yujing Li, Fada Wang, Jing Zhou, Lan-Qing Li, Chengrun Song, En-Qiang Chen
Optimal Treatment Based on Interferon No Longer Makes Clinical Cure of Chronic Hepatitis B Far Away: An Evidence-Based Review on Emerging Clinical Data. Clinical pharmacology and therapeutics 116 (2) (2024)
Xiong Pei, Wei Jiang, Lianchi Li, Qingmin Zeng, Chang-Hai Liu, Ming Wang, En-Qiang Chen, Taoyou Zhou, Hong Tang, Dong-Bo Wu
Mendelian-randomization study revealed causal relationship between nonalcoholic fatty liver disease and osteoporosis/fractures. Journal of gastroenterology and hepatology (2024)
Yujing Li, Fada Wang, Jing Zhou, Lan-Qing Li, Chengrun Song, En-Qiang Chen
Optimal Treatment Based on Interferon No Longer Makes Clinical Cure of Chronic Hepatitis B Far Away: An Evidence-Based Review on Emerging Clinical Data. Clinical pharmacology and therapeutics 116 (2) (2024)
Xiong Pei, Wei Jiang, Lianchi Li, Qingmin Zeng, Chang-Hai Liu, Ming Wang, En-Qiang Chen, Taoyou Zhou, Hong Tang, Dong-Bo Wu
Mendelian-randomization study revealed causal relationship between nonalcoholic fatty liver disease and osteoporosis/fractures. Journal of gastroenterology and hepatology 39 (5) (2024)
Yong-Hong Wang, Hong Tang, En-Qiang Chen
Quantitative Measurement of Serum HBcrAg Can Be Used to Assess the Feasibility of Safe Discontinuation of Antiviral Therapy for Chronic Hepatitis B. Viruses 16 (4) (2024)
Yachao Tao, Yonghong Wang, Menglan Wang, Hong Tang, En-Qiang Chen
Mesenchymal Stem Cells Alleviate Acute Liver Failure through Regulating Hepatocyte Apoptosis and Macrophage Polarization. Journal of clinical and translational hepatology 12 (6) (2024)
Mao-Zhu Liu, Xin-Hua Dai, Ming-Tang Zeng, En-Qiang Chen
Clinical treatment of cryptococcal meningitis: an evidence-based review on the emerging clinical data. Journal of neurology 271 (6) (2024)
Mao-Zhu Liu, Xin-Hua Dai, Ming-Tang Zeng, En-Qiang Chen
Clinical treatment of cryptococcal meningitis: an evidence-based review on the emerging clinical data. Journal of neurology 271 (6) (2024)
Yong-Hong Wang, Hong Tang, En-Qiang Chen
Quantitative Measurement of Serum HBcrAg Can Be Used to Assess the Feasibility of Safe Discontinuation of Antiviral Therapy for Chronic Hepatitis B. Viruses 16 (4) (2024)
Yachao Tao, Yonghong Wang, Menglan Wang, Hong Tang, En-Qiang Chen
Mesenchymal Stem Cells Alleviate Acute Liver Failure through Regulating Hepatocyte Apoptosis and Macrophage Polarization. Journal of clinical and translational hepatology 12 (6) (2024)
Yujing Li, Fada Wang, Jing Zhou, Lan-Qing Li, Chengrun Song, En-Qiang Chen
Optimal Treatment Based on Interferon No Longer Makes Clinical Cure of Chronic Hepatitis B Far Away: An Evidence-Based Review on Emerging Clinical Data. Clinical pharmacology and therapeutics (2024)
Mao-Zhu Liu, Xin-Hua Dai, Ming-Tang Zeng, En-Qiang Chen
Clinical treatment of cryptococcal meningitis: an evidence-based review on the emerging clinical data. Journal of neurology (2024)
Yong-Hong Wang, Hong Tang, En-Qiang Chen
Quantitative Measurement of Serum HBcrAg Can Be Used to Assess the Feasibility of Safe Discontinuation of Antiviral Therapy for Chronic Hepatitis B. Viruses 16 (4) (2024)
Mao-Zhu Liu, Xin-Hua Dai, Ming-Tang Zeng, En-Qiang Chen
Clinical treatment of cryptococcal meningitis: an evidence-based review on the emerging clinical data. Journal of neurology 271 (6) (2024)
Yong-Hong Wang, Hong Tang, En-Qiang Chen
Quantitative Measurement of Serum HBcrAg Can Be Used to Assess the Feasibility of Safe Discontinuation of Antiviral Therapy for Chronic Hepatitis B. Viruses 16 (4) (2024)
Jing Zhou, Fa-Da Wang, Lan-Qing Li, Yu-Jin Li, Shi-Yan Wang, En-Qiang Chen
Antiviral Therapy Favors a Lower Risk of Liver Cirrhosis in HBeAg-negative Chronic Hepatitis B with Normal Alanine Transaminase and HBV DNA Positivity. Journal of clinical and translational hepatology 11 (7) (2023)
Jin-Long He, Yi-Xian You, Xiong Pei, Wei Jiang, Qing-Min Zeng, Bin Chen, Yong-Hong Wang, En-Qiang Chen, Hong Tang, Xiu-Feng Gao, Dong-Bo Wu
Tracking of Stem Cells in Chronic Liver Diseases: Current Trends and Developments. Stem cell reviews and reports (2023)
Yu-Jing Li, En-Qiang Chen
Editorial: baseline hepatitis B virus haplotype number may help predict a functional cure in patients with chronic hepatitis B treated with nucleotide analogues. Alimentary pharmacology & therapeutics 57 (5) (2023)
Lan-Qing Li, En-Qiang Chen
Editorial: in the era of effective antiviral therapy, long-term dynamic endoscopic monitoring does not seem to be necessary for all CHB patients with compensated cirrhosis. Alimentary pharmacology & therapeutics 57 (12) (2023)
Yong-Hong Wang, En-Qiang Chen
Mesenchymal Stem Cell Therapy in Acute Liver Failure. Gut and liver (2023)
Lan-Qing Li, Yiju He, Ting Liu, Jing Zhou, En-Qiang Chen
Fever of unknown origin and splenomegaly: a case report of visceral leishmaniasis diagnosed by metagenomic next-generation sequencing. Future microbiology (2023)
Jing Zhou, Fa-Da Wang, Lan-Qing Li, Yu-Jin Li, Shi-Yan Wang, En-Qiang Chen
Antiviral Therapy Favors a Lower Risk of Liver Cirrhosis in HBeAg-negative Chronic Hepatitis B with Normal Alanine Transaminase and HBV DNA Positivity. Journal of clinical and translational hepatology 11 (7) (2023)
Meng-Lan Wang, Fa-Da Wang, En-Qiang Chen
Letter: serum HBV RNA and HBcrAg may help to evaluate safely stopping nucleot(s)ide analogues in patients with HBeAg-negative chronic hepatitis B and without cirrhosis. Alimentary pharmacology & therapeutics 56 (7) (2022)
Meng-Lan Wang, En-Qiang Chen
Editorial: switching to tenofovir alafenamide monotherapy is effective and safe for other nucleos(t)ide analogues-treated patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 56 (6) (2022)
Yong-Hong Wang, Ya-Chao Tao, Dong-Bo Wu, Meng-Lan Wang, Hong Tang, En-Qiang Chen
Cell heterogeneity, rather than the cell storage solution, affects the behavior of mesenchymal stem cells in vitro and in vivo. Stem cell research & therapy 12 (1) (2021)
Zhihong Liu, Qinglong Jin, Yuexin Zhang, Guozhong Gong, Guicheng Wu, Lvfeng Yao, Xiaofeng Wen, Zhiliang Gao, Yan Huang, Daokun Yang, En-Qiang Chen, Qing Mao, Shide Lin, Jia Shang, Huanyu Gong, Lihua Zhong, Huafa Yin, Fengmei Wang, Peng Hu, Ling Xiao, Chuan Li, Qiong Wu, Chang'an Sun, Junqi Niu, Jin-Lin Hou, null null
Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 54 (9) (2021)
Meng-Lan Wang, Juan Liao, Feng Ye, Ya-Chao Tao, Dong-Bo Wu, Min He, Hong Tang, En-Qiang Chen
Distribution and factors associated with serum HBV pregenomic RNA levels in Chinese chronic hepatitis B patients. Journal of medical virology 93 (6) (2020)
Ya-Chao Tao, Meng-Lan Wang, Dong-Mei Zhang, Dong-Bo Wu, Yong-Hong Wang, Juan Liao, Hong Tang, En-Qiang Chen
Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatment. Journal of viral hepatitis 27 (7) (2020)
Ya-Chao Tao, En-Qiang Chen
Rely to: 'Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatment: Methodological issues'. Journal of viral hepatitis 28 (1) (2020)
En-Qiang Chen, M-L Wang, D-B Wu, J Liao, H Tang
Letter: impact of HBV genotypes and PC/BCP mutations on serum HBsAg levels in Chinese HBeAg-negative patients. Alimentary pharmacology & therapeutics 48 (2) (2019)
M-L Wang, En-Qiang Chen, C-M Tao, H Tang
Letter: serum HBcrAg is a useful marker for disease monitoring, predicting treatment response and disease outcome of chronic hepatitis B virus infection. Alimentary pharmacology & therapeutics 47 (12) (2019)
En-Qiang Chen, Meng-Lan Wang, Ya-Chao Tao, Dong-Bo Wu, Juan Liao, Min He, Hong Tang
Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA. Journal of viral hepatitis 26 (5) (2019)
Yong-Hong Wang, Juan Liao, Dong-Mei Zhang, Dong-Bo Wu, Ya-Chao Tao, Meng-Lan Wang, En-Qiang Chen, Hong Tang
Tenofovir monotherapy versus tenofovir plus entecavir combination therapy in HBeAg-positive chronic hepatitis patients with partial virological response to entecavir. Journal of medical virology 92 (3) (2019)
Ya-Chao Tao, Rong Deng, Meng-Lan Wang, Duo-Duo Lv, Man Yuan, Yong-Hong Wang, En-Qiang Chen, Hong Tang
Satisfactory virological response and fibrosis improvement of sofosbuvir-based regimens for Chinese patients with hepatitis C virus genotype 3 infection: results of a real-world cohort study. Virology journal 15 (1) (2018)
Yong-Hong Wang, Dong-Bo Wu, Bing Chen, En-Qiang Chen, Hong Tang
Progress in mesenchymal stem cell-based therapy for acute liver failure. Stem cell research & therapy 9 (1) (2018)
En-Qiang Chen, Tetsuro Shimakami, Yu-Chen Fan, Paolo Angeli
Acute-on-Chronic Liver Failure: From Basic Research to Clinical Applications. Canadian journal of gastroenterology & hepatology 2018 (2018)
Dong-Bo Wu, Wei Jiang, Yong-Hong Wang, Bin Chen, Meng-Lan Wang, Ya-Chao Tao, En-Qiang Chen, Hong Tang
Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotype 6 in Southwest China: Real-world experience of a retrospective study. Journal of viral hepatitis 26 (3) (2018)
Yachao Tao, Menglan Wang, En-Qiang Chen, Hong Tang
Liver Regeneration: Analysis of the Main Relevant Signaling Molecules. Mediators of inflammation 2017 (2017)